Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Teysuno“
Suchtreffer
Begriffe & Kennungen
Teysuno · 4.8 · Ocular toxicity
Eintrag öffnenTeysuno · 4.8 · Other clinical studies with Teysuno in combination with cisplatin
Eintrag öffnenTeysuno · 4.8 · Other clinical studies with Teysuno in combination with cisplatin
Eintrag öffnenTeysuno · 4.8 · Paediatric population
Eintrag öffnenTeysuno · 4.8 · Patients with renal impairment (see sections 4.2, 4.3, 4.4, and 5.2)
Eintrag öffnenTeysuno · 4.8 · Patients with renal impairment (see sections 4.2, 4.3, 4.4, and 5.2)
Eintrag öffnenTeysuno · 4.8 · Post-marketing surveillance experience in gastric cancer patients
Eintrag öffnenTeysuno · 4.8 · Post-marketing surveillance experience in gastric cancer patients
Eintrag öffnenTeysuno · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenTeysuno · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenTeysuno · 4.8 · Safety of Teysuno in patients with metastatic colorectal cancer for whom it is not possible to continue treatm
Eintrag öffnenTeysuno · 4.8 · Safety of Teysuno in patients with metastatic colorectal cancer for whom it is not possible to continue treatm
Eintrag öffnenTeysuno · 4.8 · Special populations
Eintrag öffnenTeysuno · 4.8 · Special populations
Eintrag öffnenTeysuno · 4.8 · Summary of safety profile
Eintrag öffnenTeysuno · 4.8 · Summary of safety profile
Eintrag öffnenTeysuno · 4.8 · System Organ Very Common Uncommon Rare / Very Classa common rare Infections and Neutropenic sepsis, septic sho
Eintrag öffnenTeysuno · 4.8 · System Organ Very Common Uncommon Rare / Very Classa common rare Infections and Neutropenic sepsis, septic sho
Eintrag öffnenTeysuno · 4.8 · Table 9: Adverse reactions reported by decreasing seriousness in each frequency grouping
Eintrag öffnenTeysuno · 4.8 · Table 9: Adverse reactions reported by decreasing seriousness in each frequency grouping
Eintrag öffnen